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ABSTRACT  Pathogenic  staphylococci  secrete  a  number  of  exotoxins,  including  a-toxin,  a- 
Toxin  induces  lysis of erythrocytes  and  liposomes  when  its  3S  protein  monomers  associate 
with the  lipid  bilayer and  form  a hexomeric  transmembrane  channel  3 nm  in diameter.  We 
have used a-toxin to render rat hepatocytes 93-100% permeable to trypan blue with a lactate 
dehydrogenase  leakage  <_22%. Treatment  conditions  included  incubation  for  5-10  min  at 
37°C  and  pH  7.0  with an a-toxin  concentration  of 4-35  human  hemolytic  U/ml  and  a cell 
concentration of 13-21  mg dry wt/ml. Scanning electron microscopy revealed signs of swelling 
in the treated hepatocytes, but there were no large lesions or gross damage to the cell surface. 
Transmission  electron  microscopy  indicated  that the  nucleus,  mitochondria,  and  cytoplasm 
were similar  in control  and treated cells  and  both  had  large  regions  of well-defined  lamellar 
rough  endoplasmic  reticulum.  Comparisons  of the  mannose-6-phosphatase  and  glucose-6- 
phosphatase activities  demonstrated that 5-10 U/ml a-toxin rendered cells  freely  permeable 
to glucose-6-phosphate,  while substantially preserving the selective  permeability of the mem- 
branes  of  the  endoplasmic  reticulum  and  the  functionality  of  the  glucose-6-phosphatase 
system.  Thus,  a-toxin  appears  to  have  significant  potential  as  a  means  to  induce  selective 
permeability to small  ions.  It should make possible  the study of a variety of cellular functions 
in situ. 
The study of the relationship of enzymic activities to internal 
cell structure requires the development of assay systems that 
can determine these activities in situ. For most reactions, the 
development  of  such  assays  requires  circumventing  the 
permeability barrier presented by the plasma membrane. The 
use  of toluene  (1,  2)  or  detergents  to  render  the  plasma 
membrane  permeable  to  ionic  substrates  is  unsatisfactory 
since such agents induce permeability changes in intracellular 
membranes. Toluene treatment also results in large morpho- 
logical changes  in  the  internal  cell structure  (2).  The  ideal 
reagent would be one that selectively reacts with the plasma 
membrane, does not induce any alterations of cellular mor- 
phology, and does not cause leakage of cytosolic enzymes. 
Filipin (3-7), digitonin (8-12), and saponin (13-15), all of 
which complex with membrane-bound cholesterol, have been 
used to create permeability in cells to a variety of substances. 
Since the plasma membrane has a higher cholesterol content 
than most internal  membranes (e.g.,  mitochondria and the 
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endoplasmic  reticulum  [ER]'),  it  has  been  postulated  that 
these agents would react preferentially with the plasma mem- 
brane (6,  7,  1  l,  13). In spite of this selective interaction, the 
use of filipin or digitonin can cause extensive changes in cell 
morphology (12,  16,  17).  2 The rough ER is especially vulner- 
able, and other studies show that these agents alter the kinetics 
of ER enzymes (Lange, A. J., B. F. McEwen, and W. J. Arion, 
unpublished observations; and references 18-20), which sug- 
gests the agents interact with the ER membrane or ER pro- 
teins. Because of the structural similarity of saponin to digi- 
tonin (21), saponin interaction with the ER membrane is also 
expected. Thus, these agents are unsatisfactory for use in the 
in situ characterizations of at least some enzymic activities in 
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glucuronyltransferase). 
a-Haemolysin, or a-toxin, is an exotoxin secreted by path- 
ogenic staphylococci that causes lysis of erythrocytes (22-24). 
a-Toxin forms characteristic ring structures in the membranes 
with which it interacts (25, 26). Fiissle et al. (27) demonstrated 
that the rings, 2.5-3.0 nm in diameter, are hexomers of a 34- 
kD  protein  that  is  the  a-toxin  monomer.  The  hexomers 
induce resealed ghosts to leak inulin (5 kD) but not myoglobin 
(17  kD).Thelestam and  M611by (28)  demonstrated that  in 
contrast to more detergent-like cytolytic agents, a-toxin (and 
similar pore-forming agents) causes the leakage of small ions 
(e.g.,  a-aminoisobutyric acid,  molecular weight  103) from 
human  diploid  fibroblasts  without causing the  leakage  of 
polynucleotides (<10 kD) or RNA (>200 kD). Cassidy et al. 
(29) exploited this characteristic of a-toxin to study the effect 
of Ca  +2, Sr  +2, and ATP on tension and relaxation of rabbit 
ileum smooth muscle. 
Since Bernheimer et al. (26) observed that a-toxin reacted 
with rat hepatocyte plasma membranes to form the charac- 
teristic rings,  we reasoned that it could be used to render 
hepatocytes permeable  to  ionic  substrates  while  retaining 
cytosolic enzymes.  Because  it  is  a  pore-forming agent,  it 
seemed likely that the action of a-toxin would be more specific 
and more easily controlled than that of filipin or digitonin 
which form large irregular lesions in the hepatocyte plasma- 
lemma (5, 12, 17, 21).2 This report documents the interactions 
of a-toxin with rat hepatocytes. A preliminary report describ- 
ing portions of this study has been presented (30). 
MATERIALS  AND  METHODS 
Materials:  a-Toxin was a generous gift from Behringwerke (Marburg, 
West Germany).  Filipin  was a girl from the Upjohn Co.  (Kalamazoo,  MI). 
Collagenase type Cls II was obtained  from Worthington  Biochemical Corp. 
(Freehold, N  J). Fixatives and other electron microscopy supplies were obtained 
from either Electron Microscopy Sciences (Ft. Washington, PA) or Ted Pella, 
Inc. (Irvine, CA). a2p-labeled hexose-6-phosphates were prepared as described 
previously (31). Glutathione,  saponin,  ATP,  NADH, NADPH, trypan blue, 
and lactate dehydrogenase (LDH) assay reagents were purchased  from Sigma 
Chemical Co. (St. Louis, MO). Cacodylic acid, also from Sigma Chemical Co., 
was recrystallized  from 95%  ethanol  (32). Other chemicals  were the  purest 
commercial grade available. 
The crude, lyophilized a-toxin preparation was >90% protein, as determined 
by the biuret procedure (33). The preparation was assayed for hemolytic activity 
with human erythrocytes, as described by Bernheimer and Schwartz (34) and 
was found to have 4.7 U/mg of a dry (lyophilized) a-toxin preparation.  From 
WadstrOm's data that compares the hemolytic potency of a-toxin with human 
and  rabbit  erythrocytes  (35), this  is  equivalent  to  -400--500  U  of rabbit 
hemolytic activity per milligram of protein,  or roughly equivalent to the stage 
three  a-toxin  described  by  Bernheimer  and  Schwartz  (34). Stock  a-toxin 
solutions  (94 U/ml) were prepared  by dissolving 20 mg of toxin in  1 ml of 
suspension buffer. 
Preparation  of Hepatocytes:  The animals  used  in these  studies 
were either Sprague-Dawley or Long-Evans male rats (Blue Spruce Farms, Inc., 
Altamont,  NY) weighing between 200 and 350 g. Animals were housed indi- 
vidually in  wire cages under a  12:12 h  light/dark  cycle and fed ad libitum 
Agway Pro Lab  (14% protein,  6%  fat,  75%  carbohydrate,  and 4.5% fiber) 
(Agway Inc., Syracuse, NY). Hepatocytes were prepared by the method of Berry 
(36), as modified by Cornell et al. (37). The perfusion media contained  0.03- 
0.04%  (wt/vol)  collagenase  without  hyaluronidase  in  Ca  ÷2-  and  Mg÷2-free 
Krebs-Henseleit buffer. The perfusion was continued  for 25-30 min at 37"C. 
The hepatocytes were liberated from the digested liver by gentle teasing, filtered 
through a 250-urn nylon mesh, and collected by centrifugation  (1.5 rain at 33 
g). The cells were washed three  times with complete  Krebs-Henseleit  buffer 
(containing  Ca  ÷2 and Mg  ÷2) and resuspended in media described below. Cell 
viability, as judged  by trypan  blue exclusion,  was typically between  90 and 
95%. 
Preparation of Permeabilized Ceils:  For treatment  with a-toxin, 
the washed hepatocytes were suspended to -140 mg/ml wet wt in a buffer, pH 
7.0, containing  20 mM 3-(N-morpholino)propanesulfonic  acid (MOPS), 250 
mM mannitol,  3 mM MgCI2, 3 mM ATP,  and 5 mM reduced glutathione. 
Between 0.04 and 0.20 ml of the a-toxin stock solution was added to 0.05 or 
0.25 ml of hepatocyte suspension, and suspension buffer was added to give a 
final incubation volume of  0.40 ml. The hepatocyte suspension was then flushed 
with 95:50z/CO2 and placed in a shaking water bath at 37°C for the indicated 
times. 
The  procedures  for treatments  with  filipin  described  by Jorgenson  and 
Nordlie (6) and Gankema et al. (7) were followed as closely as possible. 
Trypan  Uptake and  Leakage of  Lactate  Oehydrogen- 
ase:  Uptake  of trypan blue was measured as the percentage of cells stained 
with dye as scored under the optical microscope. LDH activity was assayed in 
cell-free supernatants according to Sigma Technical Bulletin No. 340UV (Sigma 
Chemical Co.) with the following modifications:  temperature  correction  was 
ignored; the assay volume was scaled down to 1.0 ml; and NADH levels were 
adjusted to give a starting optical density of  ~ 1.0. To determine total hepatocyte 
LDH activity (i.e., 100% leakage), hepatocytes were exposed at 37"C either for 
20  min to  500  ~M  filipin  or for  10  min to  500  /~g/ml saponin.  Cell-free 
supernatants  were obtained  by centrifuging 0.1  ml of cell suspension for 15 s 
at 9,000 g in a Beckman Microfuge B (Beckman Instruments, Inc., Fullerton, 
CA), and an 0.05-ml aliquot of the supernatant was diluted to 0.5 ml with 0.1 
M potassium phosphate, pH 7.5. 
Hexose-6-phosphatase  Assays:  To assay phosphohydrolase activ- 
ities with 2 mM mannose-6-phosphate  or 2 mM giucose-6-phosphate bepato- 
cytes were exposed to a-toxin  for 5 rain at 37°C in a buffer system (denoted 
medium C) that contained  5 mM KP~ (Pi, inorganic phosphate),  3 mM ATP, 
0.5 mM ADP, 5 mM MgC2, 0.5 mM NAD, 0.125 mM NADP, 5 mM reduced 
giutathione, 4 mM lactate, 5 mM alanine,  10 mM glucose, 140 mM mannitol, 
0.48 mM CaClz, 1.0 mM EGTA, 51.3 mM KCI, and 2% (wt/vol) bovine serum 
albumin (defatted) at a final pH of 7.0. Immediately after toxin treatment,  20 
pl of cell suspension was added to 80 pl of medium C that had been supple- 
mented  to 2  mM 32P-labeled hexose-6-phosphate  and equilibrated  at  30*(?. 
After 4 min at 30°C, the reaction was stopped by addition  of 0.9 ml of 1.25 M 
perehloric  acid  that contained  0.25 mM KPi and 0.2  mM KIO3. A 0.5-ml 
aliquot of the protein-free supernatant was transferred to a  10 x  75-ram glass 
tube and mixed with 0.1  ml of 8% ammonium molybdate. The 32P-phospho- 
molybdate was then quantitatively extracted into 0.9 ml of isobutanol/benzene, 
vol/vol (38). 
Aliquots (0.5 ml) of the organic phase were mixed with 5 ml of Liquiscint 
(National Diagnostics, Inc., Sommerville, N  J), and radioactivity was measured 
in a  Beckman  Model  LS2800 liquid  scintillation  counter (Beckman  Instru- 
ments, Inc.). All samples were corrected for radioactive decay and for nonen- 
zymatic hydrolysis of substrates by running ~zero-time" controls, wherein the 
perehloric acid solution was added to the assay medium before the addition of 
cell suspensions. 
Liver homogenates ( 10% wt/vol)  were prepared in 0.25 M sucrose containing 
5 mM HEPES, pH 7.4, as described previously (39). After diluting the homog- 
enates  with  10  vol  of medium C,  untreated  homogenates  were assayed as 
described  for  permeabilized  cells. Liver  preparations  in  which  membrane 
permeability  barriers  were completely  lacking (termed  fully disrupted)  were 
prepared as follows. Washed hepatocytes (~75  mg wet wt) were suspended in 
1.0 ml of 50 mM Tris-cacodylate buffer, pH 7.0 (38). The cell suspension was 
sonicated at 23°C for 3 rain at maximum power in a bath-type ultasonic cleaner 
(Model G112SIT, Laboratory  Supplies, Inc., Hicksville, NY). A 50-1zl aliquot 
of the sonic suspension was cooled to 0"C and diluted with 40 ul of ice-cold 50 
mM Tris-cacodylate, pH 7.0, and supplemented to 0.2% sodium deoxycholate 
by addition of 10 pl of a 2% detergent solution. After 20 rain on ice, 1.0 ml of 
medium C was added, and 20-td aliquots were assayed for phosphatase activities 
as described above,  except the assay period  was increased to  10  min.  Fully 
disrupted  homogenates  were  prepared  and  assayed by  processing  50  pl  of 
homogenate exactly as described above for the sonicated cell suspension. 
Electron Microscopy:  Hepatocytes  were fixed for electron  micros- 
copy with 2.5% glutaraldehyde (30-90  min at 4°C) and 1% osmium tetroxide 
(30 min at room temperature).  The samples were then dehydrated  with an 
ascending ethanol series. Usually a sample in the last absolute ethanol solution 
was divided  so  that  one  portion  could  be  used  for transmission  electron 
microscopy and another portion  could be used for scanning electron  micros- 
copy. For transmission  electron microscopy, samples were embedded in Spurr 
media, and silver sections were cut with a diamond knife. Sections were stained 
with 2% alcoholic uranyl  acetate (35% ethanol,  12.5% methanol),  Reynolds 
lead citrate (40), and viewed at 80 kV with a Philips EM300 electron microscope 
(Philips  Electronic  Instruments, Inc.,  Mahwah,  N  J).  For scanning  electron 
microscopy, the absolute ethanol was displaced by liquid carbon dioxide which 
served as the transitional  fluid for critical point drying.  Dried samples were 
mounted on aluminum stubs and coated with gold-palladium  using a sputter 
coater. Samples were viewed with an AMRI000 scanning electron microscope 
(Amray, Inc., Bedford, MA). 
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Conditions for Treating Cells with a-Toxin 
In a series of preliminary evaluations, we sought conditions 
whereby a-toxin might induce permeability in hepatocytes to 
trypan  blue  (molecular weight  1,000)  but  not  to  cytosolic 
enzymes such as LDH (molecular weight  140,000).  Concen- 
trations of a-toxin from 1 to 50 U/ml in suspensions of cells 
ranging between 5 and 21  mg dry wt/ml (18-73 mg wet wt/ 
ml) were exposed for up to 30 min at 37"C.  Permeability to 
trypan blue was not induced at room temperature (23"C)  or 
below. These evaluations revealed that greatest permeability 
to  trypan  blue  with  minimal  leakage  of  LDH  could  be 
achieved when moderate cell concentrations (10-21  mg dry 
wt/ml) were incubated at 37"C _10 min with relatively high 
concentrations of a-toxin (20-45 U/ml). 
We recently evaluated two published procedures (6, 7) that 
use filipin to permeabilize rat hepatocytes (16,  17).  2 We have 
also used saponin, which has been reported to induce perme- 
ability in cells (13-15). Table I compares the effectiveness of 
a-toxin with other agents in inducing permeability to trypan 
blue in rat hepatocytes while maintaining low LDH leakage. 
Whereas the filipin treatment described by Gankema et al. 
(7) could be used to achieve this differential permeability, it 
was a difficult procedure to control, and lower LDH leakage 
was invariably accompanied by lower trypan blue uptake.  2 
The data in Table I show that a-toxin is more effective than 
the other agents in inducing differential permeability. 
Morphology of a-Toxin-treated Cells 
Figs.  1 and 2 compare the internal morphology of hepato- 
cytes before and  after treatment with  a-toxin.  The  micro- 
graphs for control hepatocytes shown in Fig.  1 agree well with 
accepted standards for the morphology of undamaged paren- 
chymal cells (36, 41, 42).  a-Toxin-treated hepatocytes (Fig. 
2)  show  large  areas  of intact  and  unswollen  granular  ER. 
There is some loss of  gray background in the cytosol compared 
with control cells, but this occurs to a much lesser extent than 
it does with filipin-treated cells. 2 Likewise, the mitochondrial 
swelling is less in these cells, and intact cristae are visible. The 
nuclear membrane is intact, although rearrangement of chro- 
matin is seen in the nucleus proper. In general, the internal 
morphology of hepatocytes is reasonably well-preserved after 
exposure to a-toxin. 
Scanning electron micrographs of  control and toxin-treated 
cells are shown in Fig.  3, A and B. Many microvilli are still 
visible  in  both  preparations,  a-Toxin-treated  cells  appear 
swollen, but the large surface lesions observed after treatments 
with filipin (17) ~ or digitonin (12) are not seen. 
Assays of Glucose-6-phosphatase  Activity in 
a- Toxin-treated Cells 
The  hydrolytic component  of the  glucose-6-phosphatase 
system, which is localized on the lumenal aspect of the ER 
membrane and nuclear envelope, catalyzes the hydrolysis of 
both mannose-6-phosphate and glucose-6-phosphate (43-45). 
However, since these membranes are impermeable to man- 
nose-6-phosphate (44-46), the expression of mannose-6-phos- 
phatase activity occurs only if the permeability barrier defined 
by the ER membranes is damaged, such as by detergents, or 
otherwise modified such as could occur on reaction with a- 
toxin. Thus, assessments of the latency  ~ of mannose-6-phos- 
phatase activity provide a  means to quantify the  extent of 
disruption or permeabilization of ER membranes (44, 45). 
Part A of Table II summarizes the effects of a-toxin con- 
centration on the uptake oftrypan blue and phosphohydrolase 
activities with mannose-6-phosphate (M6Pase) and glucose- 
6-phosphate (G6Pase). Part B gives enzyme activities in total 
liver  homogenates  prepared  from  littermates  and  assayed 
without prior exposure to a-toxin. In control cells incubated 
in the absence of a-toxin, <20%  of total cellular glucose-6- 
phosphatase activity was expressed. This agrees with the per- 
centage  of cells  stained  with  trypan  blue.  The  glucose-6- 
phosphatase activity increased with increasing a-toxin until 
maximal expression was achieved at 4.7  U/ml.  In contrast, 
complete staining with trypan blue was not obtained even at 
the highest concentration of toxin used.  The highest rate of 
glucose-6-phosphate  hydrolysis  obtained  in  permeabilized 
cells was in  good  agreement with  the  value  obtained with 
untreated homogenates. 
Except at the  highest concentration  of a-toxin, the  man- 
nose-6-phosphatase activity in toxin-treated cells or untreated 
homogenates was only ~10%  of the activity with glucose-6- 
phosphate. This should be compared with the value of near 
70% observed with fully disrupted cell or homogenate prep- 
arations.  Moreover, over this range of toxin concentration, 
the mannose-6-phosphatase activity was <10% of the maxi- 
mal potential for mannose-6-phosphate hydrolysis expressed 
in cells or homogenates after disruption with sodium deoxy- 
cholate. 
Finally, the internal morphology of cell  preparations that 
3  Latency is defined as the percentage of activity in fully detergent- 
disrupted preparations  that  is  not  expressed in  preparations  not 
exposed to detergents. Latency is calculated as 100 (detergent-treated 
activity -  untreated activity)/detergent-treated activity. 
TABLE  I 
Trypan Blue Uptake and LDH Leakage  in Rat Hepatocytes Treated with Filipin, Saponin, or a-Toxin 
Agent  Agent concentration  Cell concentration  Treatment time  Trypan blue uptake  LDH leakage 
mg dry wtlml  rain  %  % 
None  0  21  0  9 +  2  8 ±  2 
None  0  21  30  16 +  4  19 _  2 
Filipin I*  100 pM  1  10  100  90-100 
Filipin I1'  50 pM  20  1  75-90  25-40 
Saponin  80 ~/ml  13-16  5  90-1 O0  60-90 
e-Toxin  35 U/ml  13  5  93  12 
a-Toxin  35 U/ml  13  10  100  22 
* From the procedure of Jorgenson  and Nordlie (6). 
t From the procedure of Gankema et al. (7). 
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￿
Control hepatocytes in Krebs-Henseleit butter. Freshly isolated hepatocytes were prepared for electron microscopy
as described in Materials and Methods . M, mitochondria ; Nu, nuclei ; rer, rough endoplasmic reticulum ; ser, smooth endoplasmic
reticulum . Bars, 1 .0 pM .
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1925FIGURE 2  Hepatocytes treated with c~-toxin.  The concentrations  of ~x-toxin  and cells during treatment were 35 U/ml and 16 mg 
dry wt/ml, respectively. After a 10-min incubation at 37°C, the hepatocytes were fixed for electron microscopy. M, mitochondria; 
Nu, nuclei; rer, rough endoplasmic reticulum. Bar, 1.0 pM. 
1926  THE  JOURNAL OF  CELL BIOLOGY • VOLUME  100,  1985 FIGURE  3  Scanning electron micrographs, (A) Control hepatocytes. (B) Hepatocytes  treated  with a-toxin as described in Fig. 2. 
Bars, 1.0 #M. 
TABLE  II 
Trypan Blue Uptake and Hexose-6-phosphatase  Activities with Glucose-6-phosphate  (C6Pase)  and Mannose-6-phosphate  (M6Pase)  in 
Hepatocytes Exposed to Various Concentrations of a-Toxin 
M6Pase  Trypan blue 
a-Toxin  M6Pase activity  G6Pase activity  G6Pase  uptake 
Ulml  #mol/minlg wet wt 
A. Hepatocytes  0  0.11  0.98  0.11  18 
0.047  0.12  1.2  0,11  21 
0,14  0.16  1.4  0.12  18 
0.35  0.18  1.4  0,13  20 
0,94  0.32  2,6  0.12  27 
1.9  0,43  4.6  0,09  26 
2,4  0.37  4.6  0,08  21 
4.7  0.40  5.0  0,08  29 
9.4  0.39  4.9  0.08  45 
18,8  0.50  5.1  0.10  70 
37.6  0.90  5.2  0,17  94 
0 
Fully disrupted*  5.4  7.9  0.72  -- 
8. Homogenates  Untreated  0.52  5.3  0.10  -- 
Fully disrupted*  4.7  6.8  0.69  -- 
Mean values for triplicate assays from two experiments are presented. In part A, hepatocytes from fed rats (22 mg dry wt/ml) were exposed for 5 min to the 
indicated concentration  of a-toxin and assayed  for phosphohydrolase activities, as described in Materials and Methods. Phosphatase  activities measured in 
total liver homogenates from fed littermates of the rats used in part A are presented in part B. 
* The designation "Fully disrupted"  indicates that liver preparations were treated  with 0.2% sodium deoxycholate before the conduct  of enzymic  assays  (see 
Materials and Methods). 
had been exposed for 5  min at 37"C to a-toxin (2.4-9.4 U/ 
ml)  and then incubated for 3-5  min  at  30°C with either 2 
mM glucose-6-phosphate or 2 mM mannose-6-phosphate was 
indistinguishable from that shown in Fig.  2.  These  findings 
indicate  that  under  conditions  in  which  a-toxin  induced 
maximal permeability of the plasma membrane to glucose-6- 
phosphate, both the native permeability of the ER membranes 
and  the  functionality  of the  glucose-6-phosphatase  system 
were substantially preserved. 
DISCUSSION 
This  report  presents  evidence  that  a-toxin  can  be  used to 
render rat hepatocytes permeable to trypan blue and glucose- 
6-phosphate  under conditions which  preserve  the  selective 
permeability of the ER membranes and cause only low leak- 
age of LDH and minimal disruption of internal morphology. 
To our knowledge, this is the first report demonstrating that 
a-toxin can be used to modify the permeability of the plasma 
membrane of hepatocytes, although this was suggested by the 
study  of Bernheimer  et  al.  (26).  Since  a-toxin  can  induce 
permeability in liposomes (26, 27), the agent does not require 
a  protein  receptor to interact with  lipid bilayers.  However, 
the hemolytic potency of a-toxin varies  widely with erythro- 
cytes from  different species (34,  35),  and Bernheimer et al. 
(22, 26) found several  bacterial  membranes that would not 
react to form characteristic  ring structures with a-toxin. These 
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membranes is influenced by the resident lipids and proteins. 
Accordingly, the appropriate titer for a-toxin must be empir- 
ically established for each cell type. 
The assays of glucose-6-phosphatase and mannose-6-phos- 
phatase (Table II) demonstrated that a-toxin can induce high 
permeability  of  the  plasmalemma  to  glucose-6-phosphate 
without significant changes in  the  selective permeability of 
the ER membranes. In control experiments (data not shown), 
we incubated homogenates (20 mg wet liver/ml) for 4  min 
with either 9.4 or 23.5  U/ml of toxin. At the lower concen- 
tration of toxin, rates of mannose-6-phosphate or glucose-6- 
phosphate hydrolysis were not significantly altered from con- 
trol homogenates incubated without added toxin, but at the 
higher concentration of toxin, mannose-6-phosphatase activ- 
ity was substantially elevated, approaching 50% of the activity 
observed in fully disrupted homogenates. These data indicate 
that a-toxin can induce permeability to mannose-6-phosphate 
when given direct access to the ER membranes. By compari- 
son, only modest activations of mannose-6-phosphatase were 
observed when cells were treated at a higher concentration of 
toxin (see Table II). These data lead us to conclude that for 
the most part, a-toxin does not penetrate into the interior of 
the  cell.  The  modest  activation  of mannose-6-phosphatase 
activity noted  in  cells  exposed to  higher  concentrations  of 
toxin  most likely reflects permeabilization of the ER mem- 
branes localized in  the  small subfraction of cells  that  have 
large surface lesions, e.g., those cells from which LDH leakage 
occurred. 
The  good  agreement  between  the  glucose-6-phosphatase 
activity in homogenates and in a-toxin-treated cells indicates 
that  (a)  permeabilization  can  be  achieved  without  loss  of 
functionality  of the  glucose-6-phosphatase  system  and  (b) 
potential kinetic barriers presented by the  a-toxin pores or 
cytoplasmic diffusion gradients do not impose significant rate 
restrictions on the glucose-6-phosphatase system in situ. These 
encouraging findings have prompted us to undertake a com- 
prehensive characterization of the glucose-6-phosphatase sys- 
tem of these cells. 
Maximal glucose-6-phosphatase activity with  2  mM sub- 
strate was obtained with <5  U/ml of a-toxin. Under these 
conditions, significant staining with trypan blue was observed 
in  only 30%  of the cells.  Since the  a-toxin pore should be 
large enough to accommodate trypan blue (26-28), the reason 
for the apparent differential permeability to glucose-6-phos- 
phate and trypan blue is not obvious. It may simply reflect 
the  difference in  the  relative ability (i.e.,  sensitivity) of the 
radiochemical and visual methods to detect penetration into 
the cells.  However, others have found that the amount of a- 
toxin required for marker release from erythrocyte ghosts (27) 
or  human  fibroblasts  (28)  depends  upon  the  size  of the 
marker. In any case, since most intracellular metabolites are 
smaller than trypan blue (molecular weight  1,000),  the con- 
ditions described in Table I probably represent the extreme 
in  what  is  necessary  to  achieve  high  rates  of  metabolite 
permeation  into  rat  liver hepatocytes.  Again,  we  note  the 
necessity of titrating the concentration of a-toxin required for 
the system under study. 
Whereas differential permeabilization was easily achieved 
with a-toxin, some increase in LDH leakage was consistently 
noted with increasing time of exposure (Table I). Leakage of 
LDH from permeabilized cells during longer incubations with 
a-toxin could be related to the osmotic swelling evidenced in 
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Fig. 3 B. In fact, osmotic swelling is the mechanism by which 
a-toxin and complement lyse erythrocytes. Lysis by the latter 
has been prevented by the addition of high concentrations of 
agents that will not pass through the complement pore (e.g., 
bovine  serum  albumin)  (47,  48).  Alternatively,  increased 
LDH leakage could be secondary to the loss from the cell of 
low molecular weight cofactors which  are necessary for the 
maintenance of cell  integrity. The inclusion of Mg  ÷÷, ATP, 
and  glutathione  in  our incubation  medium  stemmed from 
the finding of Gankema et al. (7) that these factors reduced 
LDH leakage from filipin-treated cells. Thus, it may be pos- 
sible to limit the time-dependent breakdown of the cells  by 
further modification of the incubation medium. Indeed, the 
question of what constitutes an appropriate intracellular me- 
dium remains to be definitively addressed. 
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